NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
Total Other Income
NLS Pharmaceutics AG
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Total Other Income
-$219.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Novartis AG
SIX:NOVN
|
Total Other Income
$318m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Total Other Income
-CHf189m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-37%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Total Other Income
-$20m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Total Other Income?
Total Other Income
-219.8k
USD
Based on the financial report for Dec 31, 2023, NLS Pharmaceutics AG's Total Other Income amounts to -219.8k USD.